Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Als save search
Genmab Announces that Janssen has Received Positive CHMP Opinion Recommending DARZALEX® (daratumumab) Subcutaneous (SC) Formulation for Patients with Newly Diagnosed Light-chain (AL) Amyloidosis
Published: 2021-05-21 (Crawled : 13:15) - globenewswire.com
JNJ | News | $148.22 -0.9% 3.3M
|
Health Technology
|
| O: 0.15%
H: 0.82%
C: -0.22%
GMAB | News | $28.12 -1.54% 170K
|
Health Technology
|
| O: 1.34%
H: 0.71%
C: 0.13%
positive chmp als
Enbridge CEO Al Monaco to Present at Scotiabank ESG Conference
Published: 2021-05-20 (Crawled : 23:00) - prnewswire.com
ENB 3 d | $35.365 -0.16% 1.7M
|
Industrial Services
|
| O: 0.57%
H: 0.26%
C: -0.52%
ceo conference presentation leo als
Scientists Use PacBio Sequencing to Discover Likely Pathogenic Structural Variants Linked to ALS
Published: 2021-05-19 (Crawled : 14:00) - pacb.com
PACB | $1.375 -6.46% 5.6M
|
Health Technology
|
| O: -5.66%
H: 6.39%
C: 6.3%
als
Cytokinetics and The ALS Association Renew Partnership to Advance the Fight Against ALS
Published: 2021-05-19 (Crawled : 12:00) - globenewswire.com
CYTK | $66.0 0.66% 250K
|
Health Technology
|
| O: -1.59%
H: 1.36%
C: 0.76%
partnership als
Clene Nanomedicine Presents Updated Blinded Efficacy Data from Ongoing Phase 2 RESCUE-ALS Study at the ENCALS 2021 Annual Meeting
Published: 2021-05-12 (Crawled : 13:00) - globenewswire.com
CLNN 4 | $0.3351 96K
|
|
| O: 4.53%
H: 1.12%
C: -2.89%
phase 2 ongoing als
MediciNova Receives a Notice of Intention to Grant for a New Patent Covering the Combination of MN-166 (ibudilast) and Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS) in Europe
Published: 2021-05-06 (Crawled : 01:00) - globenewswire.com
MNOV | $1.33 4.1K
|
Health Technology
|
| O: 2.35%
H: 0.23%
C: -8.05%
treatment europe sclerosis patent als mn-166 riluzole
Seelos Therapeutics Receives Positive EMA Opinion on Orphan Drug Designation for SLS-005 (Trehalose) in Amyotrophic Lateral Sclerosis (ALS)
Published: 2021-04-20 (Crawled : 12:00) - biospace.com/
SEEL | $0.295 -9.81% 460K
|
Health Technology
|
| O: 0.0%
H: 2.6%
C: 2.0%
positive drug sclerosis ema als designation
FirstBanc of Alabama, Inc. of Talladega, AL, parent company of First Bank of Alabama Completes Acquisition SouthFirst Bank
Published: 2021-04-19 (Crawled : 15:15) - prnewswire.com
FRBA | News | $11.92 -3.25% 25K
|
Finance
|
| O: 0.0%
H: 0.09%
C: -0.26%
acquisition als
Non-profit Partnership Spurs Phase 3 Clinical Trial for Patients With Rare Genetic Form Of ALS
Published: 2021-04-08 (Crawled : 12:00) - biospace.com/
IONS | $42.1 0.62% 290K
|
Health Technology
|
| O: -0.23%
H: 0.37%
C: -1.97%
partnership genetic phase 3 trial als rare
Enbridge CEO Al Monaco to Present at Scotiabank CAPP Conference
Published: 2021-04-05 (Crawled : 16:00) - prnewswire.com
ENB 3 d | $35.365 -0.16% 1.7M
|
Industrial Services
|
| O: 0.24%
H: 0.19%
C: 0.16%
ceo conference presentation leo als
Ionis initiates Phase 3 trial of novel antisense medicine to treat leading cause of juvenile-onset ALS
Published: 2021-04-05 (Crawled : 12:00) - prnewswire.com
IONS | $42.1 0.62% 290K
|
Health Technology
|
| O: 0.6%
H: 3.61%
C: 3.35%
phase 3 trial als
Avicanna Enters Strategic Partnership with Al Harrington’s, Viola, for commercialization of Viola branded products in Canada
Published: 2021-03-23 (Crawled : 12:00) - globenewswire.com
JNJ | News | $148.22 -0.9% 3.3M
|
Health Technology
|
| O: -0.18%
H: 0.62%
C: 0.09%
partnership commercialization als
Sorrento Announces First Patient Treated in Phase IB AL Amyloidosis Trial with STI-6129, an Anti-CD38 Antibody-Drug Conjugate
Published: 2021-03-18 (Crawled : 13:30) - globenewswire.com
SRNE | $0.015 56K
|
Health Technology
|
| O: -1.2%
H: 2.83%
C: -4.35%
antibody drug trial als
Polsinelli PC and Barry Law Office, LLC Announce a Notice for Breckenridge Brewery of Colorado LLC, et al. v. ONEOK, Inc., et al.
Published: 2021-03-12 (Crawled : 16:00) - prnewswire.com
OKE | $80.38 0.04% 600K
|
Industrial Services
|
| O: 1.31%
H: 1.06%
C: 1.06%
XEL | $55.515 0.44% 1.7M
|
Utilities
|
| O: -0.79%
H: 2.01%
C: 1.16%
als
Biohaven Announces Completion Of 50% Enrollment Ahead Of Timelines In Verdiperstat Pivotal HEALEY ALS Platform Trial At Massachusetts General Hospital
Published: 2021-03-10 (Crawled : 00:05) - prnewswire.com
BHVN | News 0 d | $38.425 -2.99% 260K
|
Health Technology
|
| O: 2.38%
H: 4.18%
C: 2.68%
trial als enroll
Clene Nanomedicine Announces Achievement of 50% Enrollment in the Phase 3 HEALEY ALS Platform Trial
Published: 2021-03-09 (Crawled : 14:00) - globenewswire.com
CLNN 4 | $0.3351 96K
|
|
| O: 1.46%
H: 14.78%
C: 10.73%
phase 3 trial platform als enroll
Pomerantz LLP and Holzer & Holzer, LLC Announce a Notice of Pendency and Proposed Settlement of Class Action in LARRY ENRIQUEZ v. NABRIVA THERAPEUTICS PLC, et al.
Published: 2021-02-26 (Crawled : 15:12) - prnewswire.com
NBRV | $1.42 1.39% 720K
|
Health Technology
|
| O: 1.66%
H: 2.65%
C: -2.45%
als
BrainStorm Announces High-Level FDA Feedback on NurOwn® ALS Clinical Development Program
Published: 2021-02-22 (Crawled : 16:00) - biospace.com/
BCLI A | $0.5398 2.82% 92K
|
Health Technology
|
| O: -28.99%
H: 2.86%
C: -6.53%
fda als program
Thermal Kinetics is Awarded Al-Corn Clean Fuels Sanitizer-Grade Ethanol Project
Published: 2021-02-10 (Crawled : 22:00) - globenewswire.com
RCMT | $19.45 2.15% 23K
|
Industrial Services
|
| O: 168.16%
H: 26.23%
C: -38.35%
als awards
Century Aluminum and Glencore to Supply 150,000 metric tons of Natur‐Al™ to Hammerer Aluminium Industries
Published: 2021-02-04 (Crawled : 13:05) - globenewswire.com
CENX | $17.385 -0.94% 460K
|
Non-Energy Minerals
|
| O: 1.69%
H: 2.03%
C: 2.03%
als
Gainers vs Losers
| 55% | 45% |
Top 10 Gainers
CSSE 4 | $0.3499 129.74% 150M
|
Consumer Services
CZOO | $11.04 121.24% 9.6M
|
BOF | $1.88 60.68% 98M
|
AMST | $3.2 60.0% 63M
|
Technology Services
LICN | $0.8592 53.43% 13M
|
WIMI | $1.03 41.99% 15M
|
Technology Services
MULN | News | $3.675 34.62% 11M
|
Information
RILY | $28.605 31.7% 9.9M
|
Finance
RBBN 4 | $3.305 28.6% 1.9M
|
Electronic Technology
RCAT | $1.53 27.5% 2.9M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.